Protective effect of heme oxygenase-1 gene transfer against oxyhemoglobin-induced endothelial dysfunction

Daihiko Eguchi, Deborah Weiler, Jawed Alam, Karl A Nath, Zvonimir S Katusic

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The current study was designed to determine the effect of recombinant heme oxygenase-1 (HO-1) gene expression on endothelial function in cerebral arteries. Isolated canine basilar arteries were exposed ex vivo (30 minutes at 37°C) to an adenoviral vector (10 10 PFU/mL, total volume 300 μL) encoding either the HO-1 gene (AdCMVHO-1) or the β-galactosidase (β-Gal) reporter gene (AdCMVβ-Gal). Twenty-four hours after transduction, arterial rings were suspended in organ chamber for isometric force recording. Endothelium-dependent relaxations were obtained in response to bradykinin (10- 10 to 10 -6 mol/L) during contraction to uridine-5′-triphosphate (UTP; 3 x 10 -6 to 3 x 10 -5 mol/L). Certain rings were incubated with oxyhemoglobin (OxyHb; 10 -5 mol/L) overnight (16 to 18 hours of 24 hours). Expression and localization of recombinant protein were shown by Western blot analysis and immunohistochemistry. Endothelium-dependent relaxation to bradykinin and endothelium-independent relaxation to forskolin (10 -9 to 10 -5 mol/L) and DEA-NONOate (10 -10 to 10 -5 mol/L) were identical in β-Gal- and HO-1-transduced arteries. Exposure to OxyHb caused impairment of endothelium-dependent relaxation to bradykinin (P < 0.01). In contrast, OxyHb did not affect endothelium-dependent relaxation in arteries expressing recombinant HO-1 (P > 0.05). This protective effect of HO-1 was reversed by coincubation with tin protoporphyrin (SnPP9; 10-5 mol/L), a selective inhibitor of HO-1 (P < 0.01). Basal levels of 3′,5′-cyclic monophosphate (cGMP) in HO-1-transduced vessels were not significantly different from those in β-Gal-transduced vessels. Pretreatment with OxyHb significantly reduced cGMP level in β-Gal-transduced rings (P < 0.01), whereas it had no effect in HO-1-transduced rings. These results demonstrate that HO-1 gene transfer does not affect endothelial and smooth muscle function of normal arteries, and that expression of recombinant HO-1 in cerebral arteries protects vasomotor function against OxyHb-induced injury.

Original languageEnglish (US)
Pages (from-to)1215-1222
Number of pages8
JournalJournal of Cerebral Blood Flow and Metabolism
Volume21
Issue number10
StatePublished - 2001

Fingerprint

Oxyhemoglobins
Heme Oxygenase-1
Genes
Endothelium
Bradykinin
Uridine Triphosphate
Cerebral Arteries
Arteries
Galactosidases
Basilar Artery
Colforsin
Reporter Genes
Recombinant Proteins
Smooth Muscle
Canidae
Western Blotting
Immunohistochemistry
Gene Expression

Keywords

  • Canine basilar artery
  • Gene transfer
  • Heme oxygenase
  • Oxyhemoglobin
  • SnPP9

ASJC Scopus subject areas

  • Endocrinology
  • Neuroscience(all)
  • Endocrinology, Diabetes and Metabolism

Cite this

Protective effect of heme oxygenase-1 gene transfer against oxyhemoglobin-induced endothelial dysfunction. / Eguchi, Daihiko; Weiler, Deborah; Alam, Jawed; Nath, Karl A; Katusic, Zvonimir S.

In: Journal of Cerebral Blood Flow and Metabolism, Vol. 21, No. 10, 2001, p. 1215-1222.

Research output: Contribution to journalArticle

@article{911c1661174c4b15b54a0b2810a70c16,
title = "Protective effect of heme oxygenase-1 gene transfer against oxyhemoglobin-induced endothelial dysfunction",
abstract = "The current study was designed to determine the effect of recombinant heme oxygenase-1 (HO-1) gene expression on endothelial function in cerebral arteries. Isolated canine basilar arteries were exposed ex vivo (30 minutes at 37°C) to an adenoviral vector (10 10 PFU/mL, total volume 300 μL) encoding either the HO-1 gene (AdCMVHO-1) or the β-galactosidase (β-Gal) reporter gene (AdCMVβ-Gal). Twenty-four hours after transduction, arterial rings were suspended in organ chamber for isometric force recording. Endothelium-dependent relaxations were obtained in response to bradykinin (10- 10 to 10 -6 mol/L) during contraction to uridine-5′-triphosphate (UTP; 3 x 10 -6 to 3 x 10 -5 mol/L). Certain rings were incubated with oxyhemoglobin (OxyHb; 10 -5 mol/L) overnight (16 to 18 hours of 24 hours). Expression and localization of recombinant protein were shown by Western blot analysis and immunohistochemistry. Endothelium-dependent relaxation to bradykinin and endothelium-independent relaxation to forskolin (10 -9 to 10 -5 mol/L) and DEA-NONOate (10 -10 to 10 -5 mol/L) were identical in β-Gal- and HO-1-transduced arteries. Exposure to OxyHb caused impairment of endothelium-dependent relaxation to bradykinin (P < 0.01). In contrast, OxyHb did not affect endothelium-dependent relaxation in arteries expressing recombinant HO-1 (P > 0.05). This protective effect of HO-1 was reversed by coincubation with tin protoporphyrin (SnPP9; 10-5 mol/L), a selective inhibitor of HO-1 (P < 0.01). Basal levels of 3′,5′-cyclic monophosphate (cGMP) in HO-1-transduced vessels were not significantly different from those in β-Gal-transduced vessels. Pretreatment with OxyHb significantly reduced cGMP level in β-Gal-transduced rings (P < 0.01), whereas it had no effect in HO-1-transduced rings. These results demonstrate that HO-1 gene transfer does not affect endothelial and smooth muscle function of normal arteries, and that expression of recombinant HO-1 in cerebral arteries protects vasomotor function against OxyHb-induced injury.",
keywords = "Canine basilar artery, Gene transfer, Heme oxygenase, Oxyhemoglobin, SnPP9",
author = "Daihiko Eguchi and Deborah Weiler and Jawed Alam and Nath, {Karl A} and Katusic, {Zvonimir S}",
year = "2001",
language = "English (US)",
volume = "21",
pages = "1215--1222",
journal = "Journal of Cerebral Blood Flow and Metabolism",
issn = "0271-678X",
publisher = "Nature Publishing Group",
number = "10",

}

TY - JOUR

T1 - Protective effect of heme oxygenase-1 gene transfer against oxyhemoglobin-induced endothelial dysfunction

AU - Eguchi, Daihiko

AU - Weiler, Deborah

AU - Alam, Jawed

AU - Nath, Karl A

AU - Katusic, Zvonimir S

PY - 2001

Y1 - 2001

N2 - The current study was designed to determine the effect of recombinant heme oxygenase-1 (HO-1) gene expression on endothelial function in cerebral arteries. Isolated canine basilar arteries were exposed ex vivo (30 minutes at 37°C) to an adenoviral vector (10 10 PFU/mL, total volume 300 μL) encoding either the HO-1 gene (AdCMVHO-1) or the β-galactosidase (β-Gal) reporter gene (AdCMVβ-Gal). Twenty-four hours after transduction, arterial rings were suspended in organ chamber for isometric force recording. Endothelium-dependent relaxations were obtained in response to bradykinin (10- 10 to 10 -6 mol/L) during contraction to uridine-5′-triphosphate (UTP; 3 x 10 -6 to 3 x 10 -5 mol/L). Certain rings were incubated with oxyhemoglobin (OxyHb; 10 -5 mol/L) overnight (16 to 18 hours of 24 hours). Expression and localization of recombinant protein were shown by Western blot analysis and immunohistochemistry. Endothelium-dependent relaxation to bradykinin and endothelium-independent relaxation to forskolin (10 -9 to 10 -5 mol/L) and DEA-NONOate (10 -10 to 10 -5 mol/L) were identical in β-Gal- and HO-1-transduced arteries. Exposure to OxyHb caused impairment of endothelium-dependent relaxation to bradykinin (P < 0.01). In contrast, OxyHb did not affect endothelium-dependent relaxation in arteries expressing recombinant HO-1 (P > 0.05). This protective effect of HO-1 was reversed by coincubation with tin protoporphyrin (SnPP9; 10-5 mol/L), a selective inhibitor of HO-1 (P < 0.01). Basal levels of 3′,5′-cyclic monophosphate (cGMP) in HO-1-transduced vessels were not significantly different from those in β-Gal-transduced vessels. Pretreatment with OxyHb significantly reduced cGMP level in β-Gal-transduced rings (P < 0.01), whereas it had no effect in HO-1-transduced rings. These results demonstrate that HO-1 gene transfer does not affect endothelial and smooth muscle function of normal arteries, and that expression of recombinant HO-1 in cerebral arteries protects vasomotor function against OxyHb-induced injury.

AB - The current study was designed to determine the effect of recombinant heme oxygenase-1 (HO-1) gene expression on endothelial function in cerebral arteries. Isolated canine basilar arteries were exposed ex vivo (30 minutes at 37°C) to an adenoviral vector (10 10 PFU/mL, total volume 300 μL) encoding either the HO-1 gene (AdCMVHO-1) or the β-galactosidase (β-Gal) reporter gene (AdCMVβ-Gal). Twenty-four hours after transduction, arterial rings were suspended in organ chamber for isometric force recording. Endothelium-dependent relaxations were obtained in response to bradykinin (10- 10 to 10 -6 mol/L) during contraction to uridine-5′-triphosphate (UTP; 3 x 10 -6 to 3 x 10 -5 mol/L). Certain rings were incubated with oxyhemoglobin (OxyHb; 10 -5 mol/L) overnight (16 to 18 hours of 24 hours). Expression and localization of recombinant protein were shown by Western blot analysis and immunohistochemistry. Endothelium-dependent relaxation to bradykinin and endothelium-independent relaxation to forskolin (10 -9 to 10 -5 mol/L) and DEA-NONOate (10 -10 to 10 -5 mol/L) were identical in β-Gal- and HO-1-transduced arteries. Exposure to OxyHb caused impairment of endothelium-dependent relaxation to bradykinin (P < 0.01). In contrast, OxyHb did not affect endothelium-dependent relaxation in arteries expressing recombinant HO-1 (P > 0.05). This protective effect of HO-1 was reversed by coincubation with tin protoporphyrin (SnPP9; 10-5 mol/L), a selective inhibitor of HO-1 (P < 0.01). Basal levels of 3′,5′-cyclic monophosphate (cGMP) in HO-1-transduced vessels were not significantly different from those in β-Gal-transduced vessels. Pretreatment with OxyHb significantly reduced cGMP level in β-Gal-transduced rings (P < 0.01), whereas it had no effect in HO-1-transduced rings. These results demonstrate that HO-1 gene transfer does not affect endothelial and smooth muscle function of normal arteries, and that expression of recombinant HO-1 in cerebral arteries protects vasomotor function against OxyHb-induced injury.

KW - Canine basilar artery

KW - Gene transfer

KW - Heme oxygenase

KW - Oxyhemoglobin

KW - SnPP9

UR - http://www.scopus.com/inward/record.url?scp=0034774790&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034774790&partnerID=8YFLogxK

M3 - Article

VL - 21

SP - 1215

EP - 1222

JO - Journal of Cerebral Blood Flow and Metabolism

JF - Journal of Cerebral Blood Flow and Metabolism

SN - 0271-678X

IS - 10

ER -